Portal portfolio company, Moonlight Therapeutics launches its first-in-human Phase I clinical trial

A significant milestone for our Atlanta-based portfolio company, Moonlight Therapeutics as the company launches its first-in-human Phase I clinical trial evaluating MOON101 for peanut allergy.